A global intelligence publication covering biotechnology, artificial intelligence, drug discovery, synthetic biology, and life-science innovation.
The Great Therapeutic Divide
The Strathmore 2026 Report
Join leaders, innovators and professionals across artificial intelligence and biotechnology for an evening focused on industry insights, new connections and meaningful collaboration.
Analysts hailed the Phase 3 head and neck cancer results as a big victory for an asset central to Genmab’s…
Read Article →
Kennedy and his MAHA movement have embraced peptides, though there's little evidence for many of the wellness compounds.
Read Article →
Nature Biotechnology, Published online: 28 October 2026; doi:10.1038/s41587-026-03343-6Dairy cows are protected from H5N1 influenza by an mRNA vaccine.
Read Article →
The plan builds on recent FDA moves to speed "personalized" treatments by offering an approval framework for therapies benefiting different…
Read Article →
Shares in GSK fell on a decline in vaccine sales in Q3, although demand for other drugs was strong with…
Read Article →
Breakthrough therapies can change the lives of patients who previously had few or no treatments for their conditions, but only…
Read Article →
A retrospective analysis of Brazil's VigiMed database identified 191 radiopharmaceutical drug entries in 126 adverse event reports, with Xofigo and…
Read Article →
BIOCENTURY | PRODUCT DEVELOPMENTORUKA RAISES EFFICACY EXPECTATIONS FOR LONG-ACTING IL-23 INHIBITORSBioCentury’s Clinical Report, Oct. 20–27
Read Article →
Astellas Pharma could secure the exclusive global rights to Audax Biosciences’ DAX-044, an antibody-cytokine fusion therapy that activates the immune system in the vicinity of the tumor.
Read Article →
Researchers report an immune-enhanced boron neutron capture therapy platform that achieved high intratumor boron-10 levels and a model-estimated 99.6 percent…
Read Article →
Explore manufacturing challenges and solutions for ADCs, bispecifics, peptides and more.
Read Article →
Nature Reviews Drug Discovery, Published online: 26 October 2026; doi:10.1038/d41573-026-00159-6Academic centres are increasingly central to advanced therapy development, but expanding…
Read Article →
Researchers uncovered the unexpected mechanism behind a cancer drug candidate, highlighting a persistent problem in drug discovery.
Read Article →Analysts hailed the Phase 3 head and neck cancer results as a big victory for an asset central to Genmab’s growth plans.
Read Article →Breakthrough therapies can change the lives of patients who previously had few or no treatments for their conditions, but only…
Read Article →A retrospective analysis of Brazil's VigiMed database identified 191 radiopharmaceutical drug entries in 126 adverse event reports, with Xofigo and…
Read Article →
In announcing the layoffs and strategic alternatives review, Artiva disclosed that two patients in the trial who underwent the study…
Read Article →
“If we want cancer vaccines to reach patients faster than BRCA testing did, there are several challenges to address now,”…
Read Article →Kennedy and his MAHA movement have embraced peptides, though there's little evidence for many of the wellness compounds.
Read Article →The plan builds on recent FDA moves to speed "personalized" treatments by offering an approval framework for therapies benefiting different…
Read Article →
The FDA has outlined a process for allowing a single application to cover multiple variants of a gene therapy. At…
Read Article →
AbbVie has filed for FDA approval of its BCMAxCD3 bispecific etentamig in multiple myeloma, a key pillar of its expansion…
Read Article →
Nature Biotechnology, Published online: 28 October 2026; doi:10.1038/s41587-026-03343-6Dairy cows are protected from H5N1 influenza by an mRNA vaccine.
Read Article →
University of Missouri researchers have created rice plants that resist bacterial blight, a devastating disease that threatens one of the…
Read Article →
Recent deaths are setbacks in drug companies’ interest in applying cancer therapy strategies to autoimmune diseases.
Read Article →
GEN editors Uduak Thomas and Julianna LeMieux, PhD, recap ASHG, highlighting key sessions, Ultima Genomics’ user group meeting, Illumina news,…
Read Article →
The disclosure makes Artiva the third company to recently report fatal events in an autoimmune cell therapy trial, following announcements…
Read Article →
Lonza brings over 40 years of experience in microbial manufacturing, spanning pilot-scale development through commercial production. The post The stranded asset problem in microbial custom manufacturing appeared first on Labiotech.eu.…
Read Article →
The biggest challenge facing the biopharma industry isn’t scientific innovation. It’s manufacturing execution. Closing this gap is one of the…
Read Article →
What is bioprocess observability? See how real-time monitoring improves process control.
Read Article →
BIOCENTURY | PRODUCT DEVELOPMENTMERCK AND MODERNA’S MELANOMA VACCINE DATA BRING ADOPTION TEST INTO FOCUSAdded benefit over adjuvant Keytruda must be…
Read Article →
Biogen is growing as planned, with marketed products generating more revenue and multiple late-stage readouts expected over the next year. Building out an early-stage pipeline would be a bonus, CEO…
Read Article →BIOCENTURY | PRODUCT DEVELOPMENTORUKA RAISES EFFICACY EXPECTATIONS FOR LONG-ACTING IL-23 INHIBITORSBioCentury’s Clinical Report, Oct. 20–27
Read Article →
The buyout hands Ferring rights to a technology capable of simplifying the lengthy and burdensome process of in vitro fertilization.
Read Article →
Kennedy on the campaign trail for MAHA, and new rules loom for U.S. investments in Chinese biotech.
Read Article →
Novartis's third-quarter results included a $1.9bn impairment relating to its $12bn takeover of Avidity, though CEO insists it remains a…
Read Article →Shares in GSK fell on a decline in vaccine sales in Q3, although demand for other drugs was strong with signs that its revamp is starting to deliver.
Read Article →
An epigenome-wide study of 1,527 Korean adults confirms core lipid–methylation loci and links ABCG1 methylation to the association between accelerated…
Read Article →
Discover our top picks of biotech incubators in Europe giving life science startups the boost they need to get off…
Read Article →
BIOCENTURY | POLITICS, POLICY & LAWSECURITY CONCERNS IN U.S., CHINA RESHAPING BIOTECHPlus: Gilead’s $1.3B PepStar deal and Merck and Moderna’s melanoma…
Read Article →
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib,…
Read Article →
In this GEN webinar, Mirjana Efremova, PhD (Queen Mary University of London) will show how these technologies can be used to analyze primary and liver-metastatic CRC patient samples to reveal…
Read Article →
Nature Biotechnology, Published online: 26 October 2026; doi:10.1038/s41587-026-03369-wGiving AI a seat at the peer review table
Read Article →
AI drug firm Pathos raises $237 million, a deal that brings together a big Tempus dataset, AI analysis from Pathos,…
Read Article →
The partnership focuses on evaluating digital patient twins, which are computer-based models of individual patients constructed from clinical and related…
Read Article →
A retrospective study of 77 breast cancer cases found that single-shot breast diffusion-weighted MRI with deep learning reconstruction received higher…
Read Article →Receive curated biotechnology intelligence, executive interviews, and publication updates delivered to your inbox.
Scan to Read
